文献速递前列腺癌

铁死亡在前列腺癌中的作用:一种新的治疗策略

The role of ferroptosis in prostate cancer: a novel therapeutic strategy.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2022-09-02

前列腺癌发病率居男性恶性肿瘤第二位,晚期可形成去势抵抗性前列腺癌(CRPC),现有手术、化疗、放疗和内分泌治疗疗效有限。铁死亡是铁依赖的脂质过氧化过程,诱导铁死亡可能成为前列腺癌的新治疗方式,本文就此综述研究进展。

要点

  • 铁死亡是铁依赖的脂质过氧化过程,与肿瘤生长相关。
  • 诱导铁死亡可能成为前列腺癌的新治疗策略。
  • 现有前列腺癌主要治疗为手术、化疗、放疗和内分泌治疗,疗效未满足预后需求。

核心结论

  • 诱导铁死亡可能成为前列腺癌的一种新治疗方法。

研究设计与样本

  • 综述,总结铁死亡在前列腺癌中的研究进展。

主要发现

  • 铁死亡是铁依赖的脂质过氧化过程,与包括肿瘤生长在内的多种疾病相关。
  • 近年通过诱导铁死亡抑制肿瘤生长并克服肿瘤耐药已成为研究热点。
  • 既往研究显示诱导铁死亡可能成为前列腺癌的新治疗方式。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The incidence of prostate cancer is the second most among male cancers after lung cancer. Prostate cancer develops rapidly and is inclined to metastasize, and castration-resistant prostate cancer (CRPC) can be formed in the later stage, which brings great challenges to the prognosis and treatment. At present, the main treatment of prostate cancer is generally divided into four methods: surgery, chemotherapy, radiotherapy and endocrine therapy. However, the efficacy of these methods fails to satisfy the demands of patient prognosis. Ferroptosis is a newly discovered iron-dependent process, characterized by lipid peroxidation. Ferroptosis is associated with many diseases, especially tumor growth. In recent years, inhibiting tumor growth and overcoming tumor drug resistance by inducing ferroptosis has become a hot research topic. Previous studies have shown that induction of ferroptosis may be a new treatment for prostate cancer. We review the research progress of ferroptosis in prostate cancer in order to provide highly effective therapies for patients with prostate cancer.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Wang Y, Ma Y, Jiang K, et al. The role of ferroptosis in prostate cancer: a novel therapeutic strategy. Prostate Cancer Prostatic Dis. 2022. PMID: 36056183. doi:10.1038/s41391-022-00583-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。